TCL Archive Afinitor Delayed Progression Compared To Tamoxifen Alone In Randomized Phase II Study December 31, 2010
TCL Archive Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment. July 30, 2004
TCL Archive NCI’s Share Of Gramm-Rudman Cuts For FY 1986 Is $54 Million; Staff Ponders How To Absorb It January 24, 1986
